Vaccines that target cancer could be available before the end of the decade, according to the husband and wife team behind one of the most successful Covid vaccines of the pandemic.
Uğur Şahin and Özlem Türeci, who co-founded BioNTech, the German firm that partnered with Pfizer to manufacture a revolutionary mRNA Covid vaccine, said they had made breakthroughs that fuelled their optimism for cancer vaccines in the coming years.
Speaking on the BBC’s Sunday with Laura Kuenssberg, Prof Türeci described how the mRNA technology at the heart of BioNTech’s Covid vaccine could be repurposed so that it primed the immune system to attack cancer cells instead of invading coronaviruses.
Vaccines to treat #cancer possible by 2030, say #BioNTech founders.
Uğur Şahin n Özlem Türeci say mRNA Covid vaccine tech could be repurposed to help destroy cancer cells. (They, w/ Pfizer, earlier created revolutionary mRNA #CovidVaccine)#VaccinesWorkhttps://t.co/srywPDHjKt
— Samir Kalia (@samir_kalia) October 17, 2022